PET/CT identifies breast cancer tumors not detected by other methods

07/16/2010 | HealthImaging.com

The use of 18F-FDG PET/CT helped pinpoint in 40 out of 89 breast cancer patients tumor deposits that were not detected through other tests, including mammography, CT and ultrasound. "Our findings agree with other studies in promoting regular investigations such as tumor markers and 18F-FDG PET/CT rather than awaiting the developments of physical symptoms as suggested by current guidelines since the timely detection of early recurrence may have a major impact on therapy and survival," the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC